美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      The Department of Health and Human Services backtracked on the claim that it would release ethics forms for seven new members of the Advisory Committee on Immunization Practices, detailing these member’s conflicts of interest. HSS said these documents would be released before the group’s first meeting, which never happened. (STAT News) 

      Pfizer and BioNTech asked London’s Court of Appeal to overturn the ruling that their COVID-19 vaccine infringed on one of Moderna’s patents. A year ago, the Court has ruled that one of Moderna’s two patents related to its mRNA technology was infringed upon by Pfizer and BioNTech’s Comirnaty vaccine. (Reuters) 

      Health secretary Robert F. Kennedy Jr. canceled a meeting of the U.S. Preventive Services Task Force. The cancellation comes weeks after the U.S. Supreme Court upheld Kennedy’s authority over the panel and subsequently gave him the power to reject certain recommendations. (STAT News) 

      Regeneron Pharmaceuticals and Amgen are in the midst of a court battle that is testing the legal limits of using patents to dispel competition. Other companies that sell biosimilar medicines are watching the battle play out as concerns rise over the manipulation of patents to maintain high prices for medication. (STAT News) 

      The Food and Drug Administration published over 200 rejection letters sent to drugmakers between 2020 and 2024 in an effort to increase transparency. These complete response letters are sent when the FDA determines it cannot approve an application, and the agency says publishing them gives the public insight into their decision making process. (Morningstar) 

      To read yesterday’s edition of Five things for pharma marketers to know, click here.